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Health physicists and knowledgeable clinicians
have the responsibility to counsel women of repro-
ductive age about the reproductive risks of ionizing
radiation exposure that occurs either before con-
ception or during pregnancy. Medical personnel
need to realize that lay individuals have many mis-
conceptions about the reproductive risks of ioniz-
ing radiation. Further, many patients are apprehen-
sive about the reproductive and developmental
risks of diagnostic radiological procedures. Coun-
seling patients requires knowledge of embryology,
genetics, radiation teratology, and the principles 
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SYNOPSIS
Health physicists and knowledgeable clinicians have the re-
sponsibility to counsel women of reproductive age about the
reproductive risks of ionizing radiation exposure before con-
ception or during pregnancy. It is important to realize that
lay individuals have many misconceptions about the repro-
ductive risks of ionizing radiation. Many patients who have
already had or will undergo some type of radiological test
are apprehensive about the reproductive and developmental
risks of diagnostic radiological procedures. Epidemiological
studies and animal studies indicate that high exposures of
ionizing radiation can cause miscarriage, congenital malfor-
mations, growth retardation, stillbirth, and cancer. With the
exception of cancer, there are threshold exposures for those
outcomes, with exposures below certain radiation doses not
increasing the reproductive or developmental risks. The
threshold exposure for birth defects at the most sensitive
stage of development is 0.2 Gy, and the threshold for growth
retardation and miscarriage is even higher. However, em-
bryonic loss can occur from low exposures during the pre-
implantation and presomite stages of development (“the all
or none period”). This is a stage when the embryo is more
likely to die than survive malformed. The most sensitive pe-
riod for the induction of mental retardation is from the 8th
week to the 15th week of gestation. The threshold for deter-
ministic effects increases after early organogenesis and also
as the exposure is protracted, e.g., with radionuclides or
multiple radiological procedures. Awareness that the thresh-
old dose for developmental effects increases as the fetus de-
velops complicates counseling because we do not have defin-
itive data on threshold exposures at all stages of gestation.
Ionizing radiation exposures prior to pregnancy represent a
very low risk for the increased incidence of genetic disease in
the offspring of the parents who have had radiation expo-
sures to the ovary or testes. Counseling patients requires
knowledge of embryology, genetics, radiation teratology,
and the principles of teratology in order for the counselor to
provide sympathetic, accurate, scholarly advice.
of teratology in order for the counselor to provide
sympathetic, accurate, scholarly advice. This paper
will help inform medical personnel about the real
risks to the embryo from ionizing radiation, pro-
vide suggestions on counseling patients, recom-
mend procedures to follow when evaluating a
patient, and offer guidance on when to schedule
elective X-ray studies that are needed. 
RISKS TO THE EMBRYO FROM IONIZING
RADIATION
There is no question that an acute exposure to
ionizing radiation above 0.5 Gy represents a signifi-
cant risk to the embryo, regardless of the stage of
gestation (1–8). The threshold dose for low linear en-
ergy transfer ionizing radiation that results in an in-
crease in major anatomical congenital malformations
is approximately 0.2 Gy. Although congenital mal-
formations are unlikely to be produced by radiation
during the first 14 days of human development,
there would be a risk of embryonic loss if the dose
were high. From approximately the 18th day to the
40th day postconception, the embryo is at risk for an
increased frequency of anatomical congenital mal-
formations if the embryonic exposure is greater than
0.2 Gy. Studies in mice have reported rib variation or
other skeletal variations below 0.2 Gy, but these
studies cannot be translated to human risks. The em-
bryo maintains an increased susceptibility to central
nervous system (CNS) effects, e.g., major CNS mal-
formations early in gestation and mental retardation
and microcephaly in midgestation. Of course, with
very high doses, e.g., an exposure to a few Gy in the
latter part of gestation, there can be a decrease in in-
telligence. While it is true that the embryo is sensitive
to the deleterious effects of these mid-range expo-
sures of ionizing radiation, the measurable effects
decrease as the exposure approaches the usual expo-
sures that the embryo receives from diagnostic radi-
ology procedures, which are predominantly less
than 0.05 Gy. In fact, many studies indicate that the
threshold for most embryonic radiation effects is in
the 0.2-Gy range, and that this threshold for deter-
ministic effects is raised by protraction of the radia-
tion exposure (9, 10). For example, following several
clinical diagnostic radiological procedures occurring
over a period of days, the exposure may be greater
than 0.05 Gy (8). In this case, the counselor can more
readily reassure the patient that the reproductive
risks are not increased because the exposure was
protracted. The newer techniques using CT scans
have the potential for exposing the embryo or fetus
to doses above 0.05 Gy, although there has been a
major effort by the radiologists and manufacturers to
reduce the exposure from CT scans (11–14). 
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That is why the recommendation of most offi-
cial organizations, including the National Council
on Radiation Protection and Measurements (NCRP),
indicate that exposures of 0.05 Gy or less will not in-
crease the risk of birth defects or miscarriage (3, 7, 8).
However, when the exposure exceeds the threshold
dose, the risks of radiation exposure to the human
embryo include embryonic loss, growth retarda-
tion, congenital malformations, microcephaly and
mental retardation, infertility, and carcinogenesis
(with the magnitude of the oncogenic risk to the
fetus being controversial) (15–18).
Except for carcinogenesis, all of those effects are
threshold phenomena. Therefore, radiation exposure
below 0.05 Gy represents no measurable increased
deterministic risks to the embryo. Even if one accepts
the controversial concept that the embryo is more
sensitive to the carcinogenic effects of radiation than
the child is, the risk at these low exposures is much
smaller that the spontaneous risks (Table 1). Further-
more, other studies (16–18) indicate that the estimate
of the risk of radiation-induced leukemogenesis
made by Stewart et al. (15) is exaggerated. 
Table 1 presents the spontaneous risks facing
an embryo at conception and the additional risks that
would come from a low exposure of ionizing radia-
tion (0.05 Gy). The hazards of exposures in the range
of diagnostic radiology (0.2 mGy–0.05 Gy) represent
an extremely low risk to the embryo, when compared
with the spontaneous mishaps that can befall human
embryos. Approximately 15% of clinically recog-
nized pregnancies abort spontaneously, but many
more pregnancies do not survive even to the first
missed menstrual period. Human infants have a 3%
major malformation rate at term, which rises to ap-
proximately 6% once all minor and major malforma-
tions are recognized. In spite of the fact that doses of
< 0.05 Gy can produce cellular effects and the fact that
diagnostic exposures during pregnancy may have a
small risk of malignancy in the child, the maximum
theoretical risk to human embryos exposed to doses
of 0.05 Gy or less is extremely small. When the risks
are explained to the patient, the family with a wanted
pregnancy invariably continues with the pregnancy.
It is of interest that most mothers who have been ex-
posed to ionizing radiation during their pregnancy
are concerned about all congenital malformations.
However, if they are concerned about cancer, it is pri-
marily a concern about childhood leukemia. The risk
of leukemia following fetal exposures from diagnos-
tic radiological studies is a small fraction of the spon-
taneous leukemia risk, even when the risk published
by Wakeford and Little (18) is utilized, and the risks
estimated by other investigators (16–17) are lower
than those of Wakeford and Little.
The difficulty that frequently arises is that 
the risks from diagnostic radiation are evaluated out-
side the context of the significant normal risks 
of pregnancy. Furthermore, many physicians ap-
proach the evaluation of diagnostic radiation expo-
sure with either of two extremes: a cavalier attitude,
or panic. The usual procedures in clinical medicine
are ignored, and an opinion based on meager infor-
mation is given to the patient. Frequently, it reflects
the physician’s bias about radiation effects, or his or
her ignorance of the field of radiation biology. In our
consultation records—obtained from the Internet,
telephone contacts, and correspondence over the past
five decades—we have records of patients who, fol-
lowing radiation exposure from a very low-exposure
diagnostic radiological procedure, were not properly
evaluated, but were advised to have an abortion. 
COUNSELING PATIENTS ABOUT
REPRODUCTIVE AND DEVELOPMENT RISKS 
The responsibility for evaluating risks of en-
vironmental toxicants to the pregnant patient and
her embryo may be that of the family physician, ob-
stetrician, radiologist, or health physicist. When
evaluating the risks of ionizing radiation, the coun-
selor can be faced with various clinical situations.
Four types of encounters are briefly described in the
following paragraphs.
The first situation involves a pregnant or pos-
sibly pregnant patient who presents with clinical
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symptoms that need to be evaluated. What is the ap-
propriate utilization of diagnostic radiological pro-
cedures that may expose the embryo or fetus to ion-
izing radiation? A pregnant or possibly pregnant
woman complaining of gastrointestinal bleeding or
pain or an abdominal or pelvic mass that cannot be
attributed to pregnancy deserves the appropriate
studies—including radiological ones—to diagnose
and treat her clinical problems. The studies should
be performed in a timely and appropriate manner in
order to minimize the exposure and maximize the
goal of making the correct diagnosis. The studies
should be performed at the time they are clinically
indicated, whether or not the woman is in the first or
second half of the menstrual cycle. Furthermore,
these studies should not be relegated to one portion
of the menstrual cycle. The first half of the men-
strual cycle is a time when the woman is not preg-
nant. Conception occurs midway during the men-
strual cycle. The second half of the menstrual cycle
is when the embryo has not yet initiated differentia-
tion and is less sensitive to the teratogenic effects of
radiation, although it is more sensitive to the lethal
effects of radiation. Animal studies indicate that the
threshold for lethality during this very early stage of
development is above 0.1 Gy, but one cannot apply
these results directly to the human embryo.
In another example of this first situation, if a ra-
diologist has been asked to perform an elective radi-
ological diagnostic study for employment or follow-
TABLE 1. Spontaneous risks facing an embryo at conception and the additional risk that would come from a low exposure
of ionizing radiation (0.05 Gy)a
Spontaneous risks facing 
an embryo at conception 
Type of risk (0 rad exposure) Additional risk from a 0.05-Gy exposure
Risk of very early pregnancy loss, before
the first missed period
Risk of spontaneous abortion in known-
pregnant women
Risk of major congenital malformations
Risk of severe mental retardation
Risk of childhood leukemia/year
Risk of early- or late-onset genetic disease
Prematurity
Growth retardation
Stillbirth
Infertility
350 000/106 pregnancies
150 000/106 pregnancies
30 000/106
5 000/106
40/106/year
110 000/106
40 000/106 pregnancies
30 000/106 pregnancies
20-2 000/106 pregnancies
7% of couples
0
0
0
0
<?1–3/106/year
Very low risk; the risk is in the next
generation and is not measurably 
increased with small populations
0
0
0
0
a Modified from Brent (4) and Brent (5).
mations is 0.20 Gy. Dose, timing, and the nature of
the malformation would enter into this analysis. A
genetic disease is diagnosed with approximately
15% to 25% of malformed children. If that is the
case, the malformations could not have been caused
by an intrauterine exposure to ionizing radiation.
For a counselor the most difficult situation of
the four possible ones mentioned here is when ex-
ternal radiation therapy or high exposures of ra-
dionuclides have been utilized in a pregnant
woman or in a woman who became pregnant dur-
ing the therapy. While this is a serious situation,
there are instances when the exposure to the em-
bryo is low. Low exposures to the embryo may
occur when radiation therapy is directed toward
the head, neck, upper chest, or the extremities. Ad-
ministered radionuclides are special problems be-
cause each radionuclide has a different half-life,
metabolism, and excretion. Therefore, each patient
needs the expert evaluation of a competent medical
or health physicist to determine what the fetal ex-
posure will be or has been, depending on the nature
of the radiation exposure. Rarely, the patient may
have received the course of therapy or be in the
middle of the therapy when the pregnancy is dis-
covered. That can be very upsetting to both the pa-
tient and physician. The exposure to the fetus can
be calculated and appropriate counseling can be de-
livered. When the radiation therapist knows that
the patient is pregnant, then the situation is much
more advantageous, because the fetal exposure can
be estimated before the onset of therapy.
In order to appropriately and more com-
pletely respond to all these situations, the counselor
should rely on the extensive amount of information
that has accumulated on the effects of radiation on
the embryo. In fact, there is no environmental haz-
ard that has been more extensively studied or on
which more information is available (2–8).
Case report
The following consultation occurred by tele-
phone. Unfortunately, it is not an uncommon oc-
currence among the thousands of consultations that
the author has performed. A 27-year-old woman
(gravida 3, para 2, abortus 0) called on a Friday af-
ternoon because she was eight weeks pregnant and
was scheduled for a therapeutic abortion on Mon-
day morning. The paternal family did not accept
abortion as an option, which caused much dissen-
sion within the family. Her obstetrician and a pedi-
atric genetic counselor had advised her to have a
therapeutic abortion because at the time of concep-
tion she had had several X-ray examinations of the
abdomen, and the obstetrician and the counselor
up that is not an emergency, then the approach
should be different. The radiological study can be
postponed until the beginning of the next menstrual
period. If the patient and physician are certain the pa-
tient is not pregnant or has a negative pregnancy test
and has not had intercourse for a lengthy period, then
the elective examination can be performed at that
time. The situation is complicated when the woman
has irregular menstrual cycles. In that situation, the
diagnostic study can be performed after the next
menstrual cycle begins. However, even in that situa-
tion, a pregnancy test should be performed. 
A second clinical situation that the counselor
may face is that the patient has completed a diag-
nostic procedure that has exposed her uterus to ion-
izing radiation, such as a procedure needed to rule
out a gastrointestinal disease because of abdominal
pain. The examination revealed that the patient had
a duodenal ulcer. The procedure was necessary, but
the patient now believes she was pregnant at the
time of the procedure. If you are the counselor,
what is the proper response to this situation?
Explain that you would have proceeded with
the necessary X-ray diagnostic test whether she was
pregnant or not, since diagnostic studies that are in-
dicated in the mother have to take priority over the
possible risk to her embryo, because almost no di-
agnostic studies increase the developmental risks to
the embryo. At this time, obtain the calculated dose
to the embryo and determine the woman’s stage of
pregnancy. If the dose is below 0.05 Gy (that is, 0.05
Sv, or 5 rads), you can inform the mother that her
risks for birth defects and miscarriage have not
been increased. In fact the threshold for these ef-
fects is 0.2 Gy or greater, thus the 0.05-Gy exposure
is far from the threshold exposure.
A third clinical situation that the counselor
may face is that a woman delivers a baby with a
serious birth defect. On her first postpartum visit,
the woman recalls that she had a diagnostic X-ray
study early in her pregnancy. What is your re-
sponse when she asks you whether the baby’s mal-
formation could be caused by the radiation expo-
sure? In most instances, the nature of the clinical
malformation will rule out radiation teratogenesis.
Radiation-induced malformations have a confined
group of malformations that identifies the radiation
teratogenic syndrome, and many malformations
have never been reported even following intrauter-
ine radiation exposures that are known to produce
congenital malformations. In this situation a clinical
teratologist or radiation embryologist could be of
assistance. On the other hand, if the exposure is
below 0.05 Gy or even 0.10 Gy, it would not be sci-
entifically supportable to indicate that the radiation
exposure was the cause of the malformations. As
mentioned before, the threshold for major malfor-
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were concerned that the embryo would be mal-
formed. Dosimetry had not been performed, and an
evaluation had not been initiated. It took about 10
minutes on the telephone, by taking a reproductive
history, to determine that she became pregnant after
the diagnostic radiation studies had been com-
pleted, and that her two boys had developmental
problems (hemangioma and pyloric stenosis). The
radiology department was contacted, and they had
already calculated a fetal exposure that was < 0.01
Gy. The advice that was given to the patient over the
telephone was that the outcome of the pregnancy
still had the background risk for reproductive and
developmental risks: 30 major malformations per 
1 000 births as a minimum, and 15% for miscarriage.
She canceled the abortion, and later delivered a nor-
mal, full-term girl. This case history illustrates the
inadequate amount of data that was collected by the
physicians before counseling the patient. 
EVALUATING THE PATIENT
Case histories similar to the case just discussed
have been frequently referred to our laboratory at the
Thomas Jefferson University or to the duPont Hospi-
tal for Children. In most instances the dose to the em-
bryo is < 0.05 Gy, and frequently it is < 0.01 Gy. Our
experience has taught us that there are many vari-
ables involved in radiation exposure to a pregnant or
potentially pregnant woman. Therefore, there is no
routine or predetermined advice that can be given in
this situation. However, if the physician and the
health physicist take a systematic approach to the
evaluation of the possible effects of radiation expo-
sure, they can help the patient make an informed de-
cision about the pregnancy. This systematic evalua-
tion can begin only when the following 10 essential
pieces of information have been obtained: (1) stage of
pregnancy at the time of exposure; (2) menstrual,
medical, and reproductive history; (3) date of con-
ception (sometimes the patient knows when she con-
ceived); (4) previous pregnancy history; (5) family
history of congenital malformations and reproduc-
tive problems; (6) other potentially harmful environ-
mental factors that occurred during the pregnancy;
(7) ages of the mother and father; (8) types, dates, and
number of any radiation studies performed; (9) cal-
culation of the embryonic exposure by a medical or
health physicist or a radiologist who is familiar with
this type of evaluation; and (10) status of the preg-
nancy (wanted or unwanted).
The information contained in the evaluation
should be communicated to the patient so that the
family can arrive at a decision. The physician
should also place a summary in the medical record
stating that the patient has been informed that
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every pregnancy begins with a background risk of
problems and that the decision to continue the
pregnancy does not mean that the counselor is
guaranteeing the outcome of the pregnancy. In each
pregnancy, the individuals involved will need to
make a decision about using amniocentesis or ul-
trasound to evaluate the fetus. 
DIAGNOSTIC OR THERAPEUTIC
ABDOMINAL RADIATION IN WOMEN 
OF REPRODUCTIVE AGE
In women of reproductive age it is important
for the patient and physician to be aware of the
pregnancy status of the patient before performing
any type of X-ray procedure in which the ovaries or
uterus will be exposed. If the embryonic exposure
will be 0.05 Gy or less, the radiation risks to the em-
bryo are small when compared with the sponta-
neous risks (Table 1). Even if the exposure is 0.10
Gy, this exposure is below the threshold or no-
effect dose of 0.2 Gy for congenital malformations.
It is important to discuss the risks of radiation as
part of the preparation for the X-ray studies, at a time
when both the physician and patient are aware that
a pregnancy exists or may exist. The pregnancy sta-
tus of the patient should be determined and noted.
Because the risk of 0.05 Gy is so small, the im-
mediate medical care of the mother should take pri-
ority over the risks of diagnostic radiation exposure
to the embryo. X-ray studies that are essential for
optimal medical care of the mother and evaluation
of medical problems that need to be diagnosed or
treated should not be postponed. Once a diagnosis
has been made, elective procedures, such as em-
ployment examinations or follow-up examinations,
need not be performed on a pregnant woman, even
though the risk to the embryo is very small. If other
procedures (e.g., ultrasound) can provide adequate
information without exposing the embryo to ioniz-
ing radiation, they of course should be used. Natu-
rally, there is a period when the patient is pregnant
but the pregnancy test is negative and the men-
strual history is of little use. However, the risks of
0.05 Gy or less are extremely small during this pe-
riod of gestation (the “all or none period,” that is,
the first two weeks post conception) (1) (Table 1). 
Scheduling elective X-ray studies 
In those instances in which elective X-ray
studies need to be scheduled, it is difficult to know
whether to schedule them during the first half of
the menstrual cycle (before ovulation) or during the
second half of the cycle (when most women will not
be pregnant, but could be pregnant). Both the ge-
netic risks of diagnostic exposures to the oocyte and
the embryopathic effects on the preimplanted em-
bryo are extremely small, especially at low expo-
sures. Also, there are no data available to compare
the risk of 0.05 Gy to the oocyte (first half of the
menstrual cycle) to the risk of 0.05 Gy to the preim-
planted embryo (second half of the menstrual cycle,
following fertilization). If the diagnostic study is
performed in the first 14 days of the menstrual
cycle, should the patient be advised to defer con-
ception for several months, based on the assump-
tion that the deleterious effect of radiation to the
ovaries decreases with increasing time between
radiation exposure and a subsequent ovulation?
The physician is in a quandary because he or she is
warning the patient about a very low risk. On the
other hand, avoiding conception for several months
is not an insurmountable hardship, as indicated in
the following quote from the Biological Effects of
Ionizing Radiation (BEIR) committee report (2): “It
is not known whether the interval between irradia-
tion of the gonads and conception has a marked ef-
fect on the frequency of genetic changes in human
offspring, as has been demonstrated in the female
mouse. Nevertheless, it may be advised for patients
receiving high doses to the gonads (> 0.25 Gy) to
wait for several months after such exposures before
conceiving additional offspring.”
Because the patients exposed during diagnos-
tic radiologic procedures absorb considerably less
than 0.25 Gy, the recommendations to perform all
diagnostic elective radiological studies in the first
half of the menstrual cycle may be unnecessary. 
The importance of determining the pregnancy
status of the patient
Why expend energy to determine the preg-
nancy status of the patient if exposures < 0.05 Gy do
not measurably affect the exposed embryos, and if
it is recommended that diagnostic procedures be
performed at any time during the menstrual cycle if
necessary for the medical care of the patient?
There are various reasons why the physician
and the patient should share the burden of determin-
ing the pregnancy status before performing an X-ray
or nuclear medicine procedure that exposes the em-
bryo. One key reason is that if the physician includes
the possibility of pregnancy in the differential diag-
nosis, a small percentage of diagnostic studies may
no longer be necessary. Early symptoms of preg-
nancy may mimic certain types of gastrointestinal or
genitourinary disease. Another essential reason is
that if the physician and the patient are both aware
that pregnancy is a possibility, the physician can ex-
plain the necessity of the procedure and answer ques-
tions about the risks. It is more likely that the patient
will be reassured, having discussed these issues, if
she subsequently proves to be pregnant.
Carefully evaluating the reproductive status
of women undergoing diagnostic procedures will
prevent many unnecessary allegations of malprac-
tice (19). Surprise and anxiety stimulate many law-
suits. In some instances, the jury that considers 
the lawsuit is not concerned with cause and effect
but with the fact that something was not done prop-
erly by the physician (20, 21). In this day and age,
failure to communicate adequately can be inter-
preted as less-than-adequate medical care. These
factors are eliminated if the patient’s pregnancy sta-
tus has been evaluated properly and the situation
has been discussed with the patient. The patient will
have more confidence if the decision to continue the
pregnancy is made before the medical X-ray proce-
dure is performed, because the necessity of per-
forming the procedure will have been determined
with the knowledge that the patient was pregnant.
SINOPSIS
El asesoramiento de pacientes expuestas a
radiaciones ionizantes durante el embarazo
Los físicos que trabajan en el ámbito de la salud y los clínicos que
tienen conocimientos de radiología tienen la responsabilidad de
asesorar a las mujeres de edad fecunda acerca de los riesgos re-
productivos de la exposición a radiaciones ionizantes antes de la
concepción o durante el embarazo. Es importante entender que
las personas legas albergan muchas nociones equivocadas acerca
de los riesgos asociados con ese tipo de radiaciones. Muchas pa-
cientes que ya se han sometido o serán sometidas a algún tipo de
prueba radiológica les temen a los correspondientes riesgos re-
productivos y a las posibles consecuencias de estas pruebas diag-
nósticas para el desarrollo fetal. Según estudios epidemiológicos
y con animales, un alto grado de exposición a radiaciones ioni-
zantes puede provocar un aborto, anomalías congénitas, retraso
del crecimiento, muerte fetal y cáncer. A salvedad de esto último,
hay umbrales de exposición establecidos en relación con cada
uno de estos problemas, y una exposición por debajo de ciertas
dosis de radiación no se asocia con ninguna elevación del riesgo
de sufrir daños reproductivos o del desarrollo. El umbral de ex-
posición asociado con anomalías congénitas durante la etapa del
desarrollo de mayor vulnerabilidad es de 0,2 Gy, y el umbral en
el caso del retraso del crecimiento y del aborto espontáneo es aun
mayor. No obstante, la pérdida de un embrión puede ocurrir in-
cluso a dosis bajas durante las fases del desarrollo que preceden
a la implantación o en la fase presomática (el llamado período de
“todo o nada”). Esta es la etapa en que un embrión corre un
mayor riesgo de morir que de sobrevivir con malformaciones. El
período de mayor vulnerabilidad para la inducción de retraso
mental dura desde la octava hasta la decimoquinta semana de
gestación. El umbral para la aparición de efectos deterministas
aumenta después de la embriogénesis temprana y a medida que
la exposición se prolonga, sea, por ejemplo, por el uso de radio-
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núclidos o durante una serie de procedimientos radiológicos. El
saber que la dosis umbral que afecta al desarrollo aumenta a me-
dida que crece el feto complica el asesoramiento porque no tene-
mos datos contundentes acerca de los umbrales de exposición
para todas las etapas de la gestación. Las exposiciones a radia-
ciones ionizantes antes del embarazo acarrean un riesgo muy pe-
queño de que aumente la frecuencia de enfermedades genéticas
en hijos/hijas de madres que han recibido radiaciones en los ova-
rios o de padres que las han recibido en los testículos. Para ase-
sorar a las pacientes hay que tener conocimientos de embriolo-
gía, genética y teratología de la radiación y saber los principios
de teratología, a fin de poder aconsejar con empatía, exactitud y
dominio académico de la materia.
Palabras clave: embarazo, resultado del embarazo,
radiación ionizante, anomalías, factores de riesgo,
teratógenos, aconsejar.
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